Posted bysoshow

The longest lunar eclipse in over 500 years will occur in the early hours of November 19, lasting several hours.

The peak of the partial eclipse will take place in the predawn hours on Friday when 97% of the moon will be eclipsed by the Earth’s shadow. The previous longest partial eclipse took place in 2018 and lasted less than two hours, while this will last for several hours.

The eclipse will be visible from all 50 US states, Canada, and Mexico, as well as parts of South America, Polynesia, Australia, and China, according to NASA.

The moon will be at its farthest point from Earth during the eclipse, slowing its orbit and extending the time it takes to move out of the darkest part of the planet’s shadow, known as the umbra, as the moon, Earth, and sun will all be aligned. The Holcomb Observatory has released a video detailing what the eclipse will look like. 

The event will begin shortly after midnight and unlike a solar eclipse, no one will need special eyewear to view the phenomenon.

When the eclipse occurs, the moon will take on a reddish hue, with only a sliver of the actual moon visible. The event will last for several hours, making it the longest of its kind in 580 years, with the next lunar eclipse not occurring until May of 2022.

If you like this story, share it with a friend!

find more fun & mates at SoShow now !

Posted bysoshow

Pfizer has agreed to grant a royalty-free license to sell its anti-coronavirus pill in nearly 100 developing countries around the world.

Under the agreement signed with the Medicines Patent Pool (MPP), a UN-backed public health organization, Pfizer will not receive royalties on the sales of its promising antiviral pill in 95 poorer countries, including the states of Sub-Saharan Africa. The measure allows MPP to grant sub-licenses to “qualified” generic medicine manufacturers in each country.

The countries covered by the deal comprise around 53% of the world’s population, Pfizer said. “We believe oral antiviral treatments can play a vital role in reducing the severity of Covid-19 infections, decreasing the strain on our healthcare systems and saving lives,” Pfizer CEO Albert Bourla said. 

We must work to ensure that all people – regardless of where they live or their circumstances – have access to these breakthroughs.

During its phase-two/three trial, the drug PF-07321332, trademarked as Paxlovid, reduced the risk of hospitalization or death by 89% in Covid-19 patients who took it within three days of symptom onset. The drug is administered in combination with low-dose ritonavir, a medication used to treat HIV/AIDS. 

The UN and the World Health Organization (WHO) have long been urging companies to make vaccines and other forms of Covid-19 treatment accessible and affordable for developing countries.

Think your friends would be interested? Share this story!

find more fun & mates at SoShow now !